Cochrane · systematic review · CD008955
Interferon alpha for the adjuvant treatment of cutaneous melanoma
Mocellin, S, Lens, MB, Pasquali, S, et al. · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
SkinAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
2
current version
GRADE rated
2
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 2 · 100%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: high‐risk melanoma participants
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
First recurrence | HR 0.83 [0.78, 0.87] | 17 studies · 10345 participants | High |
Death | HR 0.91 [0.85, 0.97] | 15 studies · 9927 participants | High |